Skip to main content
New Rewards Coming Soon! ¡Se vienen nuevas recompensas!

Our Healthy Rewards Program is getting an update in September! For a sneak peek of all the changes -including new rewards and ways to redeem them-please click here.

¡Nuestro Programa Healthy Rewards tendrá su actualización en septiembre! Para ver un adelanto de todos los cambios, incluyendo nuevas recompensas y formas de canjearlas, haz clic aquí.

Abatacept (Orencia) Information Updated in TMPPM Outpatient Drug Services Handbook

Date: June 9, 2025

Attention: All Providers

Effective Date: July 1, 2025

Call to action: On July 1, 2025, the Texas Medicaid & Healthcare Partnership (TMHP) will update the Texas Medicaid Provider Procedures Manual, Outpatient Drug Services Handbook, section 6.1, “Abatacept (Orencia).” TMHP will add the following information about the drug and its age requirements:

  • Abatacept (Orencia) (procedure code J0129) is a selective T-cell costimulation modulator.
  • The age limitation for psoriatic arthritis is 2 years of age or older.

Next steps: Providers are encouraged to share this communication with their staff.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts,log into:
www.texaschildrenshealthplan.org/provideralerts.